Overview Financials News + Filings Key Docs Ownership Insiders
|
Sensei Biotherapeutics, Inc.
|
|
Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| 8-K | 10-K | 10-K | 10-K | S-1/A |
Revenues | 100.0% | | | 100.0% | 100.0% |
Cost of goods sold | 165.2% | | | 200.0% | 154.9% |
Gross profit | -65.2% | | | -100.0% | -54.9% |
General and administrative | 65.2% | | | 48.9% | 54.9% |
Depreciation | | | | 0.9% | 0.5% |
EBIT | -165.2% | | | -148.9% | -154.9% |
Pre-tax income | -159.9% | | | -200.5% | -158.5% |
Income taxes | 0.0% | | | 0.0% | 0.0% |
Net income | -159.9% | | | -0.2% | -0.2% |
|